These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 29306481)
1. Effect of calcifediol treatment on cardiovascular outcomes in patients with acute coronary syndrome and percutaneous revascularization. Navarro-Valverde C; Quesada-Gómez JM; Pérez-Cano R; Fernández-Palacín A; Pastor-Torres LF Med Clin (Barc); 2018 Nov; 151(9):345-352. PubMed ID: 29306481 [TBL] [Abstract][Full Text] [Related]
2. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease. Perera D; Crake T; Lee V Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315 [TBL] [Abstract][Full Text] [Related]
3. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial. Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P; Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988 [TBL] [Abstract][Full Text] [Related]
4. Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. Ang L; Behnamfar O; Palakodeti S; Lin F; Pourdjabbar A; Patel MP; Reeves RR; Mahmud E J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151032 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D and prognosis in acute myocardial infarction. Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome. Hassanin A; Brener SJ; Lansky AJ; Xu K; Stone GW EuroIntervention; 2015 Jul; 11(3):293-300. PubMed ID: 25136882 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention. Verdoia M; Nardin M; Rolla R; Negro F; Gioscia R; Saghir Afifeh AM; Viglione F; Suryapranata H; Marcolongo M; De Luca G; Pharmacol Res; 2020 Oct; 160():105158. PubMed ID: 32841717 [TBL] [Abstract][Full Text] [Related]
8. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M; Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542 [TBL] [Abstract][Full Text] [Related]
10. Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Wang SL; Wang CL; Wang PL; Xu H; Du JP; Zhang DW; Gao ZY; Zhang L; Fu CG; Chen KJ; Shi DZ Exp Biol Med (Maywood); 2016 Mar; 241(5):478-84. PubMed ID: 26585407 [TBL] [Abstract][Full Text] [Related]
11. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study. Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538 [TBL] [Abstract][Full Text] [Related]
12. Impacts of intensive follow-up on the long-term prognosis of percutaneous coronary intervention in acute coronary syndrome patients - a single center prospective randomized controlled study in a Chinese population. Du L; Dong P; Jia J; Li Z; Lai L; Yang X; Wang S; Yang X; Li Z; Shang X; Fan X Eur J Prev Cardiol; 2016 Jul; 23(10):1077-85. PubMed ID: 26416996 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D Deficiency in Acute Coronary Syndrome - Clinically Relevant or Incidental Finding? Knežević Praveček M; Vuković-Arar Ž; Miškić B; Hadžibegović I Cent Eur J Public Health; 2017 Sep; 25(3):185-190. PubMed ID: 29022676 [TBL] [Abstract][Full Text] [Related]
14. Prediabetes and coronary artery disease: Outcome after revascularization procedures. Cueva-Recalde JF; Ruiz-Arroyo JR; Roncalés García-Blanco F Endocrinol Nutr; 2016 Mar; 63(3):106-12. PubMed ID: 26826773 [TBL] [Abstract][Full Text] [Related]
15. Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up. Zapata GO; Lasave LI; Kozak F; Damonte A; Meiriño A; Rossi M; Carbó S; Pollice A; Paolasso E; Picabea E J Interv Cardiol; 2009 Aug; 22(4):329-35. PubMed ID: 19515083 [TBL] [Abstract][Full Text] [Related]
16. Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial. Ben-Gal Y; Mohr R; Feit F; Ohman EM; Kirtane A; Xu K; Mehran R; Stone GW Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26019142 [TBL] [Abstract][Full Text] [Related]
17. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry. Pimor A; Auffret V; Didier R; Delaunay R; Filippi E; Hacot JP; Saouli D; Rouault G; Druelles P; Bot E; Coudert I; Boulanger B; Le Guellec M; Boulmier D; Leurent G; Bedossa M; Gilard M; Le Breton H Arch Cardiovasc Dis; 2018 Nov; 111(11):656-665. PubMed ID: 29229216 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation. Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention. Verdoia M; Nardin M; Rolla R; Negro F; Gioscia R; Afifeh AMS; Viglione F; Suryapranata H; Marcolongo M; De Luca G; Eur J Intern Med; 2021 Jan; 83():62-67. PubMed ID: 32830035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]